Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 1/20/10 → 12/31/14 |
Financiación
- Wyeth Pharmaceuticals Inc: 130.568,00 US$
A Phase 3, Open-Label Single Arm Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 3 Doses of 13-Valent Pneumococcal Conjugate Vaccine in Human Immunodeficiency Virus Subjects 18 Years of Age or Older
- Greenberg, Richard (PI)